Transcriptional regulatory functions of heterogeneous nuclear ribonucleoprotein-U and -A/B in endotoxin-mediated macrophage expression of osteopontin

Journal of Immunology

Volumn 175, Issue 1, 2005, Pages 523-530

  Gao, Chengjiang ^a   Guo, Hongtao ^a   Mi, Zhiyong ^a   Wai, Philip Y ^a   Kuo, Paul C ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; HETEROGENEOUS NUCLEAR RNA; LIPOPOLYSACCHARIDE; NITRIC OXIDE; OSTEOPONTIN; RIBONUCLEOPROTEIN; RNA BINDING PROTEIN; RNA POLYMERASE II;

ANIMAL CELL; ARTICLE; CELL LINE; CHROMATIN; CONTROLLED STUDY; DNA BINDING; MACROPHAGE; MONKEY; NITROSYLATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA PROCESSING;

EID: 21244472980     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.1.523     Document Type: Article

References (34)

1. Hijiya, N., M. Setoguchi, K. Matsuura, Y. Higuchi, S. Akizuki, and S. Yamamoto S. 1994. Cloning and characterization of the human osteopontin gene and its promoter. Biochem. J. 303: 255-262.
2. Guo, X., Y. P. Zhang, D. A. Mitchell, D. T. Denhardt, and A. F. Chambers. 1995. Identification of a ras-activated enhancer in the mouse osteopontin promoter and its interaction with a putative ETS-related transcription factor whose activity correlates with the metastatic potential of the cell. Mol. Cell Biol. 15: 476-487.
3. Guo, H., C. Q. Cai, R. A. Schroeder, and P. C. Kuo. 2001. Osteopontin is a negative feedback regulator of nitric oxide synthesis in murine macrophages. J. Immunol. 166: 1079-1086.
4. Chen, H., M. Hewison, B. Hu, and J. S. Adams. 2003. Heterogeneous nuclear ribonucleoprotein (hnRNP) binding to hormone response elements: a cause of vitamin D resistance. Proc. Natl. Acad. Sci. USA 100: 6109-6114.
5. Dreyfuss, G., M. Hentze, and A. I. Lamond, 1996. From transcript to protein. Cell 85: 963-972.
6. Krecic, A. M., and M. S. Swanson. 1999. hnRNP complexes: composition, structure, and function. Curr. Opin. Cell Biol. 11: 363-371.
7. Gao, C., H. Guo, J. Wei, Z. Mi, P. Wai, and P. C. Kuo. 2004. 5-nitrosylation of hnRNP-A/B regulates osteopontin transcription in endotoxin-stimulated murine macrophages. J. Biol. Chem. 279: 11236-11243.
8. Denhardt, D. T., M. Noda, A. W. O'Regan, D. Pavlin, and J. S. Berman. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J. Clin. Invest. 107: 1055-1061.
9. O'Regan, A., and J. S. Berman. 2000. Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation. Int. J. Exp. Pathol. 81: 373-390.
10. Rangaswami, H., A. Bulbule, and G. C. Kundu. 2004. Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IκBα kinase-dependent nuclear factor κB-mediated promatrix metalloproteinase-9 activation. J. Biol. Chem. 279: 38921-38935.
11. Philip, S., A. Bulbule, and G. C. Kundu. 2001. Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-κB-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells. J. Biol Chem. 276: 44926-44935.
12. Das, R., G. H. Mahabeleshwar, and G. C. Kundu. 2003. Osteopontin stimulates cell motility and nuclear factor, J. Biol. Chem. 278: 28593-28606.
13. Ashkar, S., G. F. Weber, V. Panoutsakopoulou, Sanchirico, M. E., Jansson, M., Zawaideh, S., Rittling, S. R., Denhardt, D. T., Glimcher, M. J., and Cantor, H. 2000. ETA-1: an early component of type-1 immunity. Science 287: 860-864.
14. O'Regan, A. W., J. M. Hayden, and J. S. Berman. 2000. Osteopontin augments CD3-mediated interferon-γ and CD40 ligand expression by T cells, which results in IL-12 production from peripheral blood mononuclear cells. J. Leukocyte Biol. 68: 495-502.
15. Rittling, S. R., and D. T. Denhardt. 1999. Osteopontin function in pathology: lessons from osteopontin-deficient mice. Exp. Nephrol 7: 103-113.
16. Tian, J. Y., E. S. Sorensen, W. T. Butler, C. A. Lopez, M. S. Sy, N. K. Desai, and D. T. Denhardt. 2000. Regulation of NO synthesis induced by inflammatory mediators in RAW 264.7 cells: collagen prevents inhibition by Osteopontin. Cytokine 12: 450-457.
17. Scott, J. A., M. L. Weir, S. M. Wilson, J. W. Xuan, A. F. Chambers, and D. G. McCormack. 1998. Osteopontin inhibits inducible nitric oxide synthase activity in rat vascular tissue. Am. J. Physiol. 275: H2258-H2265.
18. Takahashi, F., K. Takahashi, K. Maeda, S. Tominaga, and Y. Fukuchi. 2000. Osteopontin is induced by nitric oxide in RAW 264.7 cells. IUBMB Life. 49: 217-221.
19. Tolnay, M., L. A. Vereshchagina, and G. C. Tsokos. 1999. Heterogeneous nuclear ribonucleoprotein DOB is a sequence-specific DNA-binding protein. Biochem. J. 338: 417-425.
20. Tay, N., S. H. Chan, and E. C. Ren. 1992. Identification and cloning of a novel heterogeneous nuclear ribonucleoprotein C-like protein that functions as a transcriptional activator of the hepatitis B virus enhancer II. J. Virol 66: 6841-6848.
21. Tomonaga, T., and D. Levens. 1995. Heterogeneous nuclear ribonucleoprotein K is a DNA-binding transactivator. J. Biol. Chem. 270: 4875-4881.
22. Wang, D., and C. R. Parrish. 1999. A heterogeneous nuclear ribonucleoprotein A/B-related protein binds to ssDNA near the 5′ end or within the genome of feline parvovirus and can modify virus replication. J. Virol. 73: 7761-7768.
23. Chen, H., B. Hu, M. A. Gacad, and J. S. Adams. 1998. Cloning and expression of a novel dominant-negative-acting estrogen response element-binding protein in the heterogeneous nuclear ribonucleoprotein family. J. Biol. Chem. 273: 31352-31357.
24. Chen, H., B. Hu, E. A. Allegretto, and J. S. Adams. 2000. The vitamin D response element-binding protein: a novel dominant-negative regulator of vitamin D-directed transactivation. J. Biol. Chem. 275: 35557-35564.
25. Michelotti, E. F., G. A. Michelotti, A. I. Aronsohn, and D. Levens. 1996. Heterogeneous nuclear ribonucleoprotein K is a transcription factor. Mol. Cell Biol. 16: 2350-2360.
26. Dempsey, L. A., L. A. Haaakahi, and N. Maizels. 1998. A specific isoform of hnRNP D interacts with DNA in the LR1 heterodimer: canonical RNA binding motifs in a sequence-specific duplex DNA binding protein. J. Biol. Chem. 273: 29224-29229.
27. Herrmann, F., M. Bossert, A. Schwander, E. Akgun, and F. O. Fackelmayer. 2004. Arginine methylation of scaffold attachment factor A by heterogeneous nuclear ribonucleoprotein particle-associated PRMT1. J. Biol. Chem. 279: 48774-48779.
28. Helbig, R., and F. O. Fackelmayer. 2003. Scaffold attachment factor A (SAF-A) is concentrated in inactive X chromosome territories through its RGG domain. Chromosoma 112: 173-182.
29. Gohring, F., B. L. Schwab, P. Nicotera, M. Leist, and F. O. Fackelmayer. 1997. The novel SAR-binding domain of scaffold attachment factor A (SAF-A) is a target in apoptotic nuclear breakdown. EMBO J. 16: 7361-7371.
30. Blanco, J. C., C. Contursi, C. A. Salkowski, D. L. DeWitt, K. Ozato, and S. N. Vogel. 2000. Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon γ-dependent cyclooxygenase 2 expression. J. Exp. Med. 191: 2131-2144.
31. Kimura, T., K. Nakayama, J. Penninger, M. Kitagawa, H. Harada, T. Matsuyama. N. Tanaka, R. Kamijo, J. Vilcek, and T. W. Mak. 1994. Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science 264: 1921-1924.
32. Salkowski, C. A., K. Kopydlowski, J. Blanco, M. J. Cody, R. McNally, and S. N. Vogel. 1999. IL-12 is dysregulated in macrophages from IRF-1 and IRF-2 knockout mice, J. Immunol. 163: 1529-1536.
33. Salkowski, C. A., S. A. Barber, G. R. Detore, and S. N. Vogel. 1996. Differential dysregulation of nitric oxide production in macrophages with targeted disruptions in IFN regulatory factor-1 and -2 genes. J. Immunol. 156: 3107-3110.
34. Bennett, B. L., R. Cruz, R. G. Lacson, and A. M. Manning. 1997. Interleukin-4 suppression of tumor necrosis factor α-stimulated E-selectin gene transcription is mediated by STAT6 antagonism of NF-κ. J. Biol. Chem. 272: 10212-10219.